| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 22 | 2023 | 333 | 6.850 |
Why?
|
| Zebrafish | 28 | 2023 | 369 | 4.690 |
Why?
|
| Melanocytes | 12 | 2023 | 77 | 3.470 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2021 | 64 | 1.780 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2022 | 51 | 1.550 |
Why?
|
| Skin Neoplasms | 4 | 2022 | 407 | 1.200 |
Why?
|
| ras Proteins | 6 | 2017 | 76 | 1.190 |
Why?
|
| Growth Differentiation Factor 6 | 2 | 2019 | 3 | 1.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2024 | 583 | 1.080 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 168 | 1.020 |
Why?
|
| Neural Crest | 3 | 2021 | 30 | 0.980 |
Why?
|
| Animals, Genetically Modified | 13 | 2021 | 310 | 0.900 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 4 | 2019 | 13 | 0.900 |
Why?
|
| Animals | 39 | 2024 | 21308 | 0.880 |
Why?
|
| Signal Transduction | 9 | 2023 | 3145 | 0.820 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 2284 | 0.750 |
Why?
|
| Carcinogenesis | 2 | 2021 | 134 | 0.710 |
Why?
|
| Cell Differentiation | 5 | 2023 | 1386 | 0.700 |
Why?
|
| Mutation | 10 | 2022 | 2658 | 0.680 |
Why?
|
| Oncogenes | 4 | 2024 | 70 | 0.660 |
Why?
|
| Vitiligo | 1 | 2022 | 120 | 0.610 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 662 | 0.560 |
Why?
|
| Neoplasms | 4 | 2019 | 1367 | 0.550 |
Why?
|
| Melanosomes | 1 | 2017 | 1 | 0.540 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2017 | 9 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 32 | 0.530 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2006 | 447 | 0.510 |
Why?
|
| Cyclic AMP | 1 | 2017 | 144 | 0.510 |
Why?
|
| Regeneration | 2 | 2015 | 125 | 0.490 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 285 | 0.470 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 235 | 0.470 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 219 | 0.450 |
Why?
|
| Genetic Variation | 1 | 2017 | 394 | 0.450 |
Why?
|
| Nevus | 4 | 2022 | 23 | 0.440 |
Why?
|
| Caenorhabditis elegans | 5 | 2006 | 706 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2023 | 205 | 0.420 |
Why?
|
| Melanoma, Experimental | 1 | 2012 | 42 | 0.370 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 1566 | 0.370 |
Why?
|
| Pigmentation | 4 | 2019 | 25 | 0.360 |
Why?
|
| Vulva | 4 | 2006 | 18 | 0.350 |
Why?
|
| Genes, Helminth | 3 | 2006 | 58 | 0.340 |
Why?
|
| Protein Methyltransferases | 1 | 2011 | 13 | 0.340 |
Why?
|
| Gene Amplification | 1 | 2011 | 27 | 0.340 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 37 | 0.340 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 72 | 0.330 |
Why?
|
| Hematopoiesis | 3 | 2017 | 127 | 0.320 |
Why?
|
| Humans | 21 | 2024 | 65109 | 0.300 |
Why?
|
| Skin | 2 | 2023 | 422 | 0.280 |
Why?
|
| Repressor Proteins | 4 | 2006 | 351 | 0.280 |
Why?
|
| Genes, APC | 1 | 2007 | 12 | 0.270 |
Why?
|
| Ligands | 2 | 2019 | 415 | 0.260 |
Why?
|
| Stem Cells | 3 | 2023 | 276 | 0.240 |
Why?
|
| Models, Animal | 3 | 2021 | 241 | 0.240 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 220 | 0.230 |
Why?
|
| HEK293 Cells | 2 | 2017 | 615 | 0.230 |
Why?
|
| TRPP Cation Channels | 1 | 2024 | 26 | 0.220 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2024 | 20 | 0.220 |
Why?
|
| Cell Adhesion Molecules | 1 | 2024 | 95 | 0.210 |
Why?
|
| MARVEL Domain-Containing Proteins | 1 | 2024 | 1 | 0.210 |
Why?
|
| Embryo, Nonmammalian | 4 | 2021 | 183 | 0.210 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 9 | 0.210 |
Why?
|
| Acetyltransferases | 1 | 2004 | 27 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 318 | 0.210 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 136 | 0.210 |
Why?
|
| Neuroblastoma | 1 | 2024 | 54 | 0.200 |
Why?
|
| Chemokines | 1 | 2024 | 92 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2017 | 299 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 182 | 0.200 |
Why?
|
| Keratinocytes | 1 | 2023 | 71 | 0.200 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 75 | 0.200 |
Why?
|
| Hair Follicle | 1 | 2023 | 36 | 0.190 |
Why?
|
| Mice | 6 | 2024 | 11097 | 0.190 |
Why?
|
| Tetraploidy | 1 | 2022 | 2 | 0.190 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2022 | 11 | 0.190 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 182 | 0.190 |
Why?
|
| Cytokinesis | 1 | 2022 | 41 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2004 | 320 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2024 | 410 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 256 | 0.180 |
Why?
|
| Cell Count | 1 | 2021 | 128 | 0.170 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.170 |
Why?
|
| Helminth Proteins | 1 | 2001 | 51 | 0.170 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 9 | 0.160 |
Why?
|
| Base Sequence | 2 | 2017 | 1329 | 0.160 |
Why?
|
| Cell Movement | 1 | 2021 | 480 | 0.150 |
Why?
|
| Biopsy | 1 | 2021 | 456 | 0.150 |
Why?
|
| Research Design | 1 | 2022 | 588 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 402 | 0.140 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 384 | 0.140 |
Why?
|
| Splenomegaly | 1 | 2017 | 22 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 372 | 0.130 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2017 | 6 | 0.130 |
Why?
|
| Thymocytes | 1 | 2017 | 23 | 0.130 |
Why?
|
| Cell Lineage | 4 | 2017 | 282 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2017 | 287 | 0.130 |
Why?
|
| In Situ Hybridization | 1 | 2017 | 213 | 0.130 |
Why?
|
| Genes, p53 | 2 | 2015 | 51 | 0.130 |
Why?
|
| Genes, Reporter | 1 | 2017 | 257 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2004 | 1552 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 204 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1979 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2017 | 610 | 0.120 |
Why?
|
| Phylogeny | 1 | 2017 | 388 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 730 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2017 | 576 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 50 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 869 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 30 | 0.110 |
Why?
|
| Kidney | 1 | 2017 | 451 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 237 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 195 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 86 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2017 | 741 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 193 | 0.100 |
Why?
|
| Disease Progression | 2 | 2020 | 1219 | 0.100 |
Why?
|
| RNA | 1 | 2017 | 426 | 0.100 |
Why?
|
| Female | 6 | 2021 | 34008 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2014 | 84 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 907 | 0.100 |
Why?
|
| Mitosis | 1 | 2015 | 222 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 95 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1036 | 0.100 |
Why?
|
| Chromatin | 1 | 2017 | 641 | 0.090 |
Why?
|
| Cytosine | 1 | 2012 | 31 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 794 | 0.090 |
Why?
|
| Phenotype | 3 | 2008 | 1231 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1630 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2012 | 127 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 24 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 23 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 687 | 0.080 |
Why?
|
| Age of Onset | 1 | 2011 | 174 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5607 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1187 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1589 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 790 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 146 | 0.080 |
Why?
|
| Blood Physiological Phenomena | 1 | 2009 | 1 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 662 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 21 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 407 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 78 | 0.070 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 1224 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 10 | 0.070 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 26 | 0.070 |
Why?
|
| Microinjections | 1 | 2008 | 68 | 0.070 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 6 | 0.070 |
Why?
|
| Polyploidy | 1 | 2007 | 13 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2008 | 104 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 297 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 79 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 70 | 0.070 |
Why?
|
| Histone Deacetylases | 2 | 2006 | 67 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2014 | 917 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 74 | 0.060 |
Why?
|
| DNA, Helminth | 1 | 2006 | 10 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 116 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2006 | 97 | 0.060 |
Why?
|
| Heterozygote | 1 | 2006 | 173 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 325 | 0.060 |
Why?
|
| Alleles | 1 | 2006 | 453 | 0.050 |
Why?
|
| Organoids | 1 | 2024 | 41 | 0.050 |
Why?
|
| Aged | 1 | 2021 | 14952 | 0.050 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2004 | 10 | 0.050 |
Why?
|
| Male | 2 | 2021 | 31025 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 111 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 165 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 59 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 162 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2024 | 373 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 17353 | 0.050 |
Why?
|
| Liver | 1 | 2008 | 869 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 364 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 18262 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2022 | 33 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 324 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 16 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 440 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 237 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 248 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 320 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 107 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2001 | 312 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 449 | 0.040 |
Why?
|
| Transgenes | 2 | 2011 | 204 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 343 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 274 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 49 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 844 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2001 | 630 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1639 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 180 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2188 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1785 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2016 | 190 | 0.030 |
Why?
|
| Neurons | 1 | 2001 | 933 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 220 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 896 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 21 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2012 | 33 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2012 | 28 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1006 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 361 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 28 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2009 | 19 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2009 | 15 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 161 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 158 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2008 | 5 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Genes, myc | 1 | 2008 | 18 | 0.020 |
Why?
|
| Albinism | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 164 | 0.020 |
Why?
|
| Endoderm | 1 | 2008 | 47 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2008 | 63 | 0.020 |
Why?
|
| beta Catenin | 1 | 2008 | 99 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 129 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 168 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 62 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 94 | 0.020 |
Why?
|
| Light | 1 | 2008 | 195 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2006 | 17 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 222 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 193 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 662 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 156 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1698 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1100 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3470 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 3762 | 0.010 |
Why?
|